2. 筋萎縮性側索硬化症 Amyotrophic lateral sclerosis Clinical trials / Disease details

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03114215 (ClinicalTrials.gov)	June 29, 2016	28/3/2017	Effect of MD1003 in Amyotrophic Lateral Sclerosis	Effect of MD1003in Amyotrophic Lateral Sclerosis: a Randomized Double Blind Placebo Controlled Pilot ...	ALS;Amyotrophic Lateral Sclerosis;Motor Neuron Disease	Drug: MD1003;Drug: Placebo oral capsule	MedDay Pharmaceuticals SA	NULL	Completed	25 Years	80 Years	All	30	Phase 2	France
2	EUCTR2015-005810-31-FR (EUCTR)	03/06/2016	24/10/2016	Effect of MD1003in amyotrophic lateral sclerosis: a randomized, double blind placebo controlled stud ...	Effect of MD1003in amyotrophic lateral sclerosis: a randomized, double blind placebo controlled stud ...	Amyotrophic lateral sclerosis MedDRA version: 19.0;Level: PT;Classification code 10002026;Term: Amyo ...	Product Code: MD1003 INN or Proposed INN: BIOTIN	MEDDAY PHARMACEUTICALS	NULL	Not Recruiting			Female: yes Male: yes	30	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	France

First Previous1Next Last